5433492026-05-195433492026-05-192026-05-195433492026-05-192026-05-19RestructuringEntityDomain15433492026-05-19RestructuringEntityDomain1xbrli:purexbrli:shares543349ACUTAAS CHEMICALS LIMITEDACUTAASNOTLISTEDINE00FF01025NewOther Restructuringtrue2026-05-1910:50:002026-05-19Board of Directors of Acutaas Chemicals Electrolytes Private Limited (“ACEPL”), a wholly owned subsidiary of Acutaas Chemicals Limited (“Company”), at its meeting held on May 19, 2026, has approved the allotment of 1,111 number of equity shares of face value of Rs. 10 (Rupees Ten Only) each at an issue price of Rs. 52,490/- per share (including premium of Rs. 52,480/- per share) on partly paid-up preferential basis by way of private placement to an Identified Investor - A.R.Z Pharma Ltd.Subsidiary1000010000100001100000.911110.100111111Acutaas Chemicals Electrolytes Private Limited ("ACEPL"), a wholly owned subsidiary of Acutaas Chemicals Limited, has issued partly paid-up equity shares on preferential basis by way of private placement to A.R.Z Pharma Ltd.Acutaas Chemicals Limited shareholding in ACEPL stands reduced from 100% to 90% of the post issue share capital of ACEPL.ACEPL has ceased to be a wholly owned subsidiary of the Company; however, it shall continue to remain a subsidiary of the Company.falsePost allotment, Acutaas Chemicals Limited shareholding in ACEPL stands reduced from 100% to 90% of the post issue share capital of ACEPL.